The COVID-19 pandemic presented ophthalmologists with the difficulty of treating patients remotely, but the widespread introduction of telehealth could be a silver lining in glaucoma management, according to Sayoko “Sy” E. Moroi, MD, PhD.
“Telehealth is here to stay. We are going to be seeing more technology development that will be patient-centered to help for glaucoma assessment,” Moroi, chair and director of the department of ophthalmology and visual sciences at the Ohio State University Wexner Medical Center, said at the virtual Prevent Blindness: Focus on Eye
Uncategorized